News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Clinical - Drug Product News
ANI Pharmaceuticals, Inc. Announces The Launch Of Propafenone Tablets 3/31/2015
Nektar Therapeutics (NKTR) Release: MOVANTIK (Naloxegol) Tablets For The Treatment Of Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Launched In The US 3/31/2015
Mylan (MYL) Launches Generic Exforge Tablets 3/31/2015
Ducere Pharma to Relaunch Ex-Novartis AG (NVS) Cruex Antifungal 3/31/2015
Teva (TEVA) Expands Hypertension Line With Launch Of Generic Exforge Tablets In The United States 3/31/2015
VIVUS, Inc. (VVUS) Updates On Qsymia Plans; Will Continue Talks With U.S., EU Regulators 3/31/2015
Ferring Pharmaceuticals Receives FDA Approval For Growth Hormone Name Change, Acquires ZOMACTON [Somatropin (rDNA Origin)] For Injection And Needle-Free Device In The U.S. 3/31/2015
Pfizer (PFE) Ad Spending Dwarfs Competitors 3/30/2015
PHEBURANE Now Available For Distribution In Canada Through Medunik Canada 3/30/2015
Par Specialty Pharmaceuticals Launches Nascobal (Cyanocobalamin, USP) Nasal Spray Single-Use Device Along With Nascobal Nutrition Direct Progrm 3/30/2015
Hospira's INFLECTRA (Infliximab) Now Available In Canada 3/30/2015
Janssen Research & Development Release: FDA Approves Label Update For ZYTIGA To Include Statistically Significant Overall Survival Results In Chemotherapy-Naive Men With Metastatic Castration-Resistant Prostate Cancer 3/30/2015
Novo Nordisk (NJ) (NVO)To Launch Novoeight In The United States For People With Hemophilia A 3/26/2015
Egalet Provides Commercial Update On SPRIX And OXAYDO 3/25/2015
Eli Lilly (LLY) Release: First-In-Class Type 2 Diabetes Treatment Glyxambi (empagliflozin/Linagliptin) Tablets For Adults Now Available In U.S. Pharmacies 3/23/2015
Stempeutics Receives Advanced Therapy Medicinal Product (ATMP) Classification From European Medicines Agency For Its Novel Stem Cell Drug 'Stempeucel' 3/23/2015
Suneva Medical Introduces Regenica Recovery Gel 3/23/2015
NEOCUTIS Launches MICRO·ESSENTIALS™ Skincare Line Powered By MPC 3/23/2015
NeoStrata Company, Inc. Launches SKIN ACTIVE Dermal Replenishment 3/20/2015
Neovasc Inc. (NVC) Launches Reducer In Select European Countries 3/20/2015
Akorn, Inc. (AKN) Launches Phenylephrine HCl Ophthalmic Solution 3/20/2015
Emisphere Technologies, Inc. (EMIS) Launches Eligen B12, The First Oral Prescription Tablet Proven To Normalize B12 Levels Without The Need For An Injection 3/19/2015
Prestium Pharma, Inc. Announces Plans For Release Of Improved OLUX (Clobetasol Propionate) Foam 3/19/2015
Novogen Limited (NVGN) Release: Potential Of Anisina To Become Major New Chemotherapy Confirmed By Coda Study 3/18/2015
Hatchtech Pty Ltd To Explore Strategic Alternatives For Commercialization Of Xeglyze Lotion In The U.S. 3/18/2015
Actavis (ACT) Receives FDA Approval For VIIBRYD (vilazodone HCl) 20mg Once Daily As A Therapeutic Dose 3/17/2015
TWi Pharmaceuticals, Inc. Announces The First Shipment Of Its Generic Product In The U.S. Market 3/17/2015
Duchesnay inc. Release: Expansion Overseas – Diclectin For Nausea And Vomiting Of Pregnancy (NVP) Now Available In Israel 3/17/2015
Allergan (AGN) Rival Ipsen (IPN.PA) to Continue U.S. Hiring Spree 3/16/2015
Endo Pharmaceuticals (ENDP) Announces The Launch Of NATESTO (Testosterone Nasal Gel), The First And Only Nasal Gel For Testosterone Replacement Therapy 3/16/2015
Yisheng Biopharma Co., Ltd. Release: A New Therapeutic Vaccine Successfully Developed Against Rabies 3/16/2015
Merz North America Announces The Availability Of Radiesse (+) With Integral 0.3% Lidocaine 3/16/2015
FDA Rates Kitabis Pak As Therapeutic Equivalent Of TOBI 3/16/2015
Genovis Is Launching A New Enzyme Product 3/12/2015
Mylan Inc. (MYL) Launches First And Only Available Intermediate Dosage Strengths Of Fentanyl Transdermal System 37.5, 62.5 And 87.5 Mcg/Hr 3/11/2015
Mylan Inc. (MYL) Launches Generic Antabuse Tablets 3/11/2015
Take Charge And Become One Of The Alpha Elite With The Launch Of Hantian Labs' Stimulant Free Testosterone And Performance Booster 3/11/2015
Mylan Inc. (MYL) Launches Generic Subutex Sublingual Tablets 3/11/2015
Akorn, Inc. (AKN) Provides Update On Recent Product Launches 3/11/2015
Vectura Group plc (VEC.L) Release: AirFluSal Forspiro Launched In Portugal And Ireland 3/11/2015
Afaxys Pharmaceuticals Announces Launch Of Econtra EZ, Its First Over-The-Counter Emergency Contraceptive 3/11/2015
BioPharmX Announces Violet Iodine Now Available At Leading National Retailer 3/10/2015
Milan, Italy: BMG Pharma S.r.l Announces The Launch Of Its Proprietary Product Ialuxid Gel In The People's Republic Of China By Luqa Pharmaceuticals 3/10/2015
ANI Pharmaceuticals, Inc. Announces The Launch of Etodolac 200mg Capsules 3/10/2015
Colorcon, Inc. Introduces Opadry Amb II – The Next Advancement In Fully Formulated Film Coating Systems For Moisture Barrier Protection Of Pharmaceutical Tablets 3/10/2015
TWi Pharmaceuticals, Inc. Receives Rare Disease Drug Designation For Its Drug Candidate AC-203 In Taiwan 3/10/2015
Actavis (ACT) Launches Generic Version Of Temovate (Clobetasol Cream 0.05%) 3/9/2015
Genentech (RHHBY) Denies Knowledge of Distribution Problems for Cancer Drugs 3/9/2015
Manzo Pharmaceuticals Announces Progress, As Retail Stores Start To Carry Tummy Relief 3/9/2015
Larasan Pharmaceutical Corporation Release: FLEX24, New All-Natural Pain Reliever Lasts 24 Hours, Longer Than Other OTC Pain Relievers; Innovative Performance Tape A First In The Market 3/9/2015
AbbVie (ABBV) CEO Believes New Form of Humira Could Confront Generics 3/6/2015
Orexo US Launches New 8.6/2.1 Mg ZUBSOLV (Buprenorphine/Naloxone) Sublingual Tablet CIII: 8.6/2.1mg 3/6/2015
Genentech (RHHBY)'s Controversial Distribution Move Deemed a Failure: Survey 3/5/2015
Akorn, Inc. (AKN) to Cease Use of its Drugs in Lethal Injections 3/4/2015
Elder Pharmaceutical Ltd. Forays Into The Rs 800 Crore Nasal Inhaler Segment With Launch Of "Solo" Inhalers 3/2/2015
Ipsen (IPN.PA) Announces Third Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S. In 2015 3/2/2015
Eisai Inc. (ESALF.PK) Release: LENVIMA (lenvatinib) Now Available Through Two Specialty Pharmacies, Accredo And Biologics, Inc. 2/27/2015
Pfizer (PFE) Release: CDC Advisory Committee On Immunization Practices Votes To Recommend Serogroup B Meningococcal Disease Vaccination For Persons At Increased Risk 2/26/2015
After Almost a Year Hiatus, GlaxoSmithKline (GSK)'s Popular Diet Pill alli Returns to Market 2/25/2015
Heritage Pharmaceuticals Initiates A Nationwide Voluntary Recall Of Colistimethate For Injection USP, 150 Mg And Rifampin For Injection USP, 600 Mg/Vial Due To A Lack Of Sterility Assurance 2/25/2015
Celltrion, Inc. (068270.KQ) Launches World’s First Biosimilar Monoclonal Antibody Remsima In 12 New European Markets 2/25/2015
TWi Pharmaceuticals, Inc. Announces That It Will Sell Its Products In The U.S. Market, Originally Planned To Be Sold By Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA 2/24/2015
Pre-Booking For Flublok Influenza Vaccine Now Available From Cardinal Health, Inc. (CAH) And McKesson Corporation 2/24/2015
Prometheon Pharma Release: Follicept Hair Growth Gel Set For Launch In 2015 By UF Transdermal Delivery Startup 2/24/2015
Celgene International Sárl (CELG) Release: ABRAXANE Now Reimbursed In Italy As A First-Line Treatment Of Adult Patients With Metastatic Pancreatic Cancer 2/24/2015
Critics Attack as Gilead (GILD) Has a Pill to Stop HIV, But Why Isn't Anyone Taking It? 2/23/2015
Tauriga Sciences Inc. (TAUG) Completes Manufacturing Of CannaCaviar CBD Soft Gels 2/23/2015
FDA Grants Seven Years’ Market Exclusivity To Eagle Pharmaceuticals (EGRX)’ Ryanodex For The Treatment Of Malignant Hyperthermia 2/23/2015
Ferring Pharmaceuticals Announces European Launch Of CORTIMENT MMX (Budesonide) For Ulcerative Colitis, And New Data Re-Confirms Safety And Efficacy 2/20/2015
Actavis (ACT) Receives Final Approval For Generic Version Of Subutex 2/20/2015
Aptalis Pharmaceutical Technologies (FRX) Release: Allegra Dry Syrup 5% Launches In Japan 2/20/2015
Teva Pharmaceutical Industries (TEVA) Bolsters Injectable Portfolio With Launch Of Generic Lovenox And Generic Zyvox In The United States 2/17/2015
Galderma Laboratories Announces Availability Of Soolantra® (ivermectin) Cream, 1% 2/17/2015
Hospira Launches First Biosimilar Monoclonal Antibody (mAb) Inflectra (Infliximab) In Major European Markets 2/16/2015
Actavis (ACT) Launches Generic Pulmicort RESPULES 2/16/2015
Teijin Limited Release: Small-sized MUCOSOLVAN L Expectorant Tablet 45 Mg Approved In Japan 2/16/2015
SkinCeuticals Announces The Launch of Metacell Renewal B3 2/13/2015
Gilead (GILD) Agrees to a Discounted Price of $46,000 for Sovaldi in Europe 2/13/2015
Noven Pharmaceuticals Inc. Release: New Minivelle (Estradiol Transdermal System) 0.025 mg/day Dose Now Available by Prescription in U.S. Pharmacies 2/12/2015
Ex-Smokers Jittery About GlaxoSmithKline (GSK)'s Nicorette Lozenge Shortage 2/11/2015
Aratana Therapeutics (PETX) Provides Product Updates 2/11/2015
BioLife Solutions, Inc. (BLFS.OB) Launches New Cell Thawing Media Products In Response To Worldwide Shortage Of Dextran Solutions 2/11/2015
Cumberland Pharmaceuticals (CPIX) Announces Pipeline Expansion With Boxaban (ifetroban) Oral Capsule 2/11/2015
Itonis Pharmaceuticals Distribution Of Its EMESYL(TM) Nausea Relief Seeking Marketing Evaluation To Air Infomercial With 2/11/2015
Itonis Pharmaceuticals's EMESYL(TM) Nausea Relief Convenience Store Test Market Begins In Lodi, California 2/11/2015
Newly Approved Ibrance (Palbociclib) From Pfizer (PFE) Available Through Onco360 2/9/2015
BMG Pharma S.r.l Obtained A New Indication On Molluscum Contagiosium For CE Marked Proprietary Product Ialuxid Gel 2/9/2015
Daiichi Sankyo (4568.t) Release: SAVAYSA (edoxaban) Now Available In U.S. Pharmacies 2/9/2015
Are You At Risk? Bayer HealthCare (BAY)'s Aspirin Launches The Proheart Path Tool To Assess CV Event Risk 2/9/2015
Tianjin Medical University Cancer Hospital Release: Nanocarrier Drugs for Pancreatic Cancer Now Being Produced In China 2/6/2015
AstraZeneca PLC (AZN) Release: MOVANTIK (naloxegol) Tablets Descheduled By The DEA 2/6/2015
Novartis Pharmaceuticals Canada Inc. Release: Now Available In Quebec, Ultibro® Breezhaler®, A Once-Daily Dual Bronchodilator For Chronic Obstructive Pulmonary Disease (COPD) 2/3/2015
Merck & Co. (MRK)’s Insomnia Medicine BELSOMRA® (Suvorexant) C-IV, The First And Only Orexin Receptor Antagonist, Now Available In The United States 2/3/2015
Sanofi (SAN.PA) And MannKind Corporation (MNKD) Announce Afrezza®, The Only Inhaled Insulin, Now Available In The U.S. 2/3/2015
Inergetics, Inc. Completes Final Launch Preparations For Its New CBD-Based Pain Relief Supplement 2/3/2015
Merck & Co. (MRK)'s Fake MMR Trial Data Buried Even as Measles Outbreak Shows Vaccine Surge 2/2/2015
Vertex Pharmaceuticals (MA) (VRTX) Learns From Gilead Sciences, Inc. (GILD)'s Solvadi Mistakes as it Preps for CF Drug Launch 2/2/2015
FDA Approves New Dosing Option for CSL Behring's Hizentra® 2/2/2015
PharmAthene, Inc. (PIP) rPA Antigen Formulated With DepoVax™ Demonstrates Promise As Single Unit Dose Anthrax Vaccine 2/2/2015
Octapharma USA, Inc. Launches Co-Pay Assistance Program For Patients Receiving Wilate® 2/2/2015
ANI Pharmaceuticals, Inc. Announces The Launch Of Etodolac 300mg Capsules 1/30/2015
CytoSorbents, Inc. And Aferetica Introduce CytoSorb® To Italy 1/30/2015
Novartis AG (NVS) Sees Price War With Amgen (AMGN), Eli Lilly (LLY) for Blockbuster Psoriasis Market 1/29/2015
FDA Grants QIDP Designation To Neutrolin®, CorMedix (CRMD)'s Lead Product Candidate In The U.S. 1/29/2015
Asia's Biggest Vaccine Maker a Huge Threat to Drugmakers Like Merck & Co. (MRK) 1/28/2015
Rhinomed (ASX:RNO) Release Of Next Generation Turbine Sports Technology 1/28/2015
BioSpace (DHX) Poll Finds Whopping 92% of Respondents Believe Discounts Were Offered in Pricing War 1/27/2015
MSF Not Impressed With Pfizer (PFE)'s "Tiny" Vaccine Price Cut 1/27/2015
New England Biolabs Releases Rapid PNgase F For Biotherapeutic Development And Production 1/27/2015
IMPAX Laboratories, Inc. (IPXL) Receives FDA Approval For A Generic Version Of Lamictal® Orally Disintegrating Tablets (ODT) 1/26/2015
Purdue Pharma L.P. Release: Hysingla™ ER (hydrocodone bitartrate) Extended-Release Tablets CII Now Available 1/26/2015
Pfanstiehl Laboratories Launches New cGMP-produced, Parenteral Grade Maltose For Pharmaceutical Formulations 1/26/2015
Bogus Versions of Eli Lilly (LLY)'s Cialis Found Entering the U.S. By Mail, Says FDA 1/23/2015
After Gilead (GILD)-AbbVie (ABBV)'s Hep C Price War, Express Scripts Inc. Eyes Cancer Meds Next 1/23/2015
NanoViricides, Inc. (NNVC.PK) Reports That It Has Shipped anti-Ebola Drug Candidates For Testing to a BSL-4 Hi-Security Biocontainment Laboratory 1/22/2015
Disneyland Measles Outbreak Casts Shadow on Anti-Vaccination Movement 1/21/2015
Boehringer Ingelheim Pharmaceuticals, Inc. Release: SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available In The United States 1/21/2015
International Charity Slams GlaxoSmithKline (GSK), Pfizer (PFE) for High Vaccine Prices 1/20/2015
IDEXX Laboratories, Inc. (IDXX) Announces SDMA As Important Expansion To Reference Lab Test Menu 1/19/2015
Elite Pharmaceuticals, Inc. (ELI) Announces First Shipment Of Generic Isradipine Capsules 1/16/2015
Mylan Inc. (MYL) Launches Generic Epivir-HBV® Tablets 1/16/2015
J.P. Morgan: AbbVie (ABBV) Getting "Very Compelling" Exclusive Offers for Viekira Pak, Says CFO 1/15/2015
Alimera Sciences (ALIM) Announces First Sale Of ILUVIEN® In Portugal 1/14/2015
Eli Lilly (LLY) Claims Innocence as FDA Bans Mystery Cialis-Viagra Concoction Discovered at Plant 1/14/2015
Targets Of Next Express Scripts Inc. Price War: Amgen (AMGN) and Regeneron (REGN) 1/14/2015
Frost & Sullivan Releases Drug Launch And Phase 3 Trial Watch List For Top Therapeutic Areas 1/13/2015
Breaking: J.P. Morgan: Sanofi (SAN.PA) Says Afrezza Will Be Available in 2015, Snubs MannKind Corporation (MNKD) CEO Retirement News 1/13/2015
Gilead Sciences, Inc. (GILD) Throws Another Punch at AbbVie (ABBV) by Striking Deal With Anthem, Inc. 1/12/2015
U.K. Cancer Drugs Fund Delists Big Pharmas' Meds; Novartis AG (NVS) Slams Process 1/12/2015
Hikma Pharmaceuticals (HIK.L) To Launch Colchicine 0.6mg Capsules 1/12/2015
HUYA Bioscience International Announces Regulatory Approval Of Chidamide, The First Selective HDAC Inhibitor In China 1/12/2015
Perrigo Company (PRGO) Launches The Generic Version Of Clobex® (Clobetasol Propionate) Spray, 0.05% 1/12/2015
Perrigo Company (PRGO) Launches AB Therapeutic Equivalent Testosterone Gel 1.0% 1/12/2015
Life Extension Introduces Immune Senescense Protection Formula 1/12/2015
Afaxys Announces Nationwide Availability Of Tarina Fe 1/20 To The Public Health Sector, Colleges & Universities 1/12/2015
Bioo Scientific Corporation Releases 18S ITS rRNA Library Prep Kit To Simplify Eukaryotic Metagenomic Studies 1/9/2015
Impax Pharmaceuticals (IPXL) Announce FDA Approval Of RYTARY™ (Carbidopa And Levodopa) Extended-Release Capsules For The Treatment Of Parkinson's Disease 1/8/2015
Gilead Sciences, Inc. (GILD) Fights Back as CVS Will Exclusively Cover Hepatitis C Drug Harvoni 1/7/2015
Lyophilization Services of New England Receives Approval To Manufacture Commercial Aseptic Product 1/7/2015
Teva Pharmaceutical Industries Limited (TEVA) Launches Generic Diovan® In The United States 1/7/2015
Fresenius Kabi AG Introduces NAROPIN® In Freeflex® Bag 1/6/2015
Lupin Ltd. (LUPN.BO) Launches Generic DIOVAN® Tablets 1/6/2015
Mylan Inc. (MYL) Launches Generic Diovan® Tablets 1/5/2015
NovaBay Pharmaceuticals, Inc. (NBY) Rebrands Its i-Lid Cleanser As Avenova 1/5/2015
Galderma Laboratories Launches Its First Over-The-Counter Acne Regimen, Benzac® Acne Solutions 1/5/2015
Newly-Approved Keryx Biopharmaceuticals (KERX) Drug Poised to Take About $600 Million of Genzyme Corporation (GENZ)'s Sales 1/2/2015
Sagent Pharmaceuticals, Inc. Announces The Launch Of Colistimethate For Injection, USP 12/30/2014
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014
UK Agency's Rejection of Eli Lilly (LLY), GlaxoSmithKline (GSK), PharmaMar S.A.'s Ovarian Cancer Drugs Stand 12/24/2014
Express Scripts Inc. Turns to AbbVie (ABBV) In Huge Hepatitis C Deal; Shuns Gilead Sciences, Inc. (GILD) 12/24/2014
PuraMed BioScience Nears Final Stages Needed For Distribution Of MigraPure H 12/23/2014
Keryx Biopharmaceuticals (KERX) Announces Commercial Launch Of AURYXIA™ (Ferric Citrate) Tablets In The United States 12/22/2014
Jazz Pharmaceuticals (JAZZ) Receives FDA Approval For Intravenous Administration Of Erwinaze® (Asparaginase Erwinia Chrysanthemi) 12/22/2014
Mylan Inc. (MYL) Launches First Generic Version Of Vivelle-DOT® 12/22/2014
Amgen (AMGN)'s Blincyto To Carry A Hefty $178,000 Price Tag 12/19/2014
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014
NVN Therapeutics Launches Estracool™ Dietary Supplement For Reduction Of Menopausal Symptoms 12/18/2014
Putney, Inc. Launches Carprofen Chewable Tablets 12/18/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Valganciclovir Tablets, USP 12/16/2014
Actavis (ACT) Ordered To Keep Selling Alzheimer's Pill 12/12/2014
Pacira Pharmaceuticals, Inc. (PCRX) Announces Changes To EXPAREL® Label 12/12/2014
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants 12/11/2014
Abbott Laboratories (ABT)'s Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe 12/11/2014
Mylan Inc. (MYL) Launches First Generic Version Of Orapred ODT 12/11/2014
Mylan Inc. (MYL) Launches Generic Robaxin Injection 12/11/2014
Lupin Ltd. (LUPN.BO) Launches Authorized Genericfor Celebrex Capsules 12/11/2014
Mylan Inc. (MYL) Launches One Of First Available Generic Versions Of Celebrex Capsules 12/10/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of First Generic Celebrex® Capsules In The United States 12/10/2014
Actavis (ACT) Launches Generic Version Of Celebrex 12/10/2014
S.F. Men Shed Condoms In Favor Of Gilead Sciences, Inc. (GILD)'s HIV Prevention Pill Truvada 12/9/2014
BioPharmX Corporation Release: Introducing Violet Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* 12/9/2014
ConvaTec Introduces Sensi-Care Clear Zinc Skin Protectant For Diaper Rash 12/9/2014
Ignyta (RXDX) Receives Approval Of Nonproprietary Name Entrectinib For Lead Product Candidate, RXDX-101 12/9/2014
BioPharmX Corporation Release: Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort 12/9/2014
Zydus Cadila Launches World's First Biosimilar Of AbbVie (ABBV)'s Humira In India 12/9/2014
Daiichi Sankyo, Inc. (4568.t) Launches New Formulation Of LIXIANA 60 mg Tablets (edoxaban) In Japan 12/8/2014
Otsuka Pharmaceutical Co., Ltd. Release: U.S. FDA Approves The Labeling Update Of Abilify Maintena® (Aripiprazole) For Extended-Release Injectable Suspension To Describe New Clinical Data For The Treatment Of Acutely Relapsed Adults With Schizophrenia 12/8/2014
Basilea Pharmaceutica (BSLN.SW) Announces Launch Of Antibiotic Zevtera(R) (Ceftobiprole Medocaril) In Germany 12/5/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved In Germany 12/4/2014
PTC Therapeutics, Inc. (PTCT) Announces Launch Of Translarna (ataluren) In Germany 12/3/2014
Galderma Laboratories, L.P. Release: The Cetaphil® Brand Launches New Cetaphil® Baby Line 12/3/2014
Suneva Medical Release: Bellafill To Replace ArteFill As New Brand 12/2/2014
EPIRUS Biopharmaceuticals Remicade® Biosimilar, Infimab™, Launches In India 12/2/2014
Pfanstiehl Laboratories Launches cGMP-Produced, Parenteral Grade Mannitol For Pharmaceutical Formulations 12/2/2014
Catylix And Aspira Scientific Launch The First Reagent For Pentafluoroethylation 12/2/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Exforge HCT® Tablets In The United States 12/1/2014
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014
flutiform® Launched In Spain; Abriff® Launched In Italy SkyePharma Inc. (SKYE) To Receive €2 Million Milestone From Mundipharma International Limited 12/1/2014
Actavis (ACT) Launches Generic Version Of Intuniv 12/1/2014
FDA Warning: PML Death Associated With Biogen Idec (BIIB)'s Tecfidera 11/26/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Docetaxel Injection USP 11/24/2014
Perrigo Company (PRGO) Announces The Launch Of A Generic Version Of Astellas' Protopic Ointment 0.1% And 0.03% 11/24/2014
Sanofi (SAN.PA) Aims To Launch 18 New Drugs By 2020 11/21/2014
ViaDerma Lead Product TetraStem Shows Promise in Treating Acne 11/21/2014
IntelliPharmaCeutics Notes Launch Of 5mg Strength Of Focalin XR(R) Generic By Teva Pharmaceutical Industries Limited (TEVA) 11/20/2014
Endo International plc (ENDP) Announces Launch Of Generic Version Of Valcyte 11/20/2014
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Over-The-Counter Fexofenadine Hydrochloride 60 Mg And Pseudoephedrine Hydrochloride 120 Mg Extended-Release Tablets 11/20/2014
Keryx Biopharmaceuticals (KERX) Announces Trade Name Auryxia for Ferric Citrate 11/19/2014



//-->